MYO16 and head and neck squamous cell carcinoma: Furthermore, the levels of MYO5B, MYO5C, MYO6, MYO7A, and MYO16 were found downregulated in HNSCC patients, and 3 studies reported the aberrant expression of MYO1D: 2 showed increased expression, and 1 showed decreased expression (Figure 1(a)).